Further, when the expression was analyzed across different IPSS-R risk categories, it was found to be significantly lower in the higher IPSS-R risk categories (p-value: < 0.05; Mann–Whitney U test) and this reduction in the expression was similar to that in AML-MR (Fig. 1c). The gene discussed is NR3C2; the disease is acute myeloid leukemia.